Pharmacogenomics Market: Information by Product and Services (Instruments, Services), Technology (NGS, PCR), Application (CVDs) and End User (Research), and Region — Forecast till 2029

Tables and figures

TABLE 1         NUMBER OF PEOPLE AGED 65-YEARS OR OVER BY GEOGRAPHIC REGIONS IN 2019 AND 2050     

TABLE 2         TABLE OF PHARMACOGENOMIC BIOMARKERS IN DRUG LABELING | FDA

TABLE 3         POPULAR THERAPUETIC PRODUCTS | FDA       

TABLE 4         GLOBAL PHARMACOGENOMICS MARKET SHARE, BY PRODUCTS AND SERVICES, 2017—2029 ($MILLION)    

TABLE 5         GLOBAL PHARMACOGENOMICS MARKET SHARE FOR INSTRUMENTS, BY REGION, 2017 – 2029 ($ MILLION)   

TABLE 6         GLOBAL PHARMACOGENOMICS MARKET SHARE FOR CONSUMABLES, BY REGION, 2017 – 2029 ($ MILLION)   

TABLE 7         GLOBAL PHARMACOGENOMICS MARKET SHARE FOR SERVICES, BY REGION, 2017 – 2029 ($ MILLION)    

TABLE 8         GLOBAL PHARMACOGENOMICS MARKET SHARE FOR SOFTWARE, BY REGION, 2017 – 2029 ($ MILLION) 

TABLE 9         SUMMARY OF CONVENTIONAL PGX TECHNOLOGIES  

TABLE 10       GLOBAL PHARMACOGENOMICS MARKET SHARE, BY TECHNOLOGY, 2017—2029 ($MILLION)    

TABLE 11       GLOBAL PHARMACOGENOMICS MARKET SHARE FOR NEXT GENERATION SEQUENCING, BY REGION, 2017 – 2029 ($ MILLION)  

TABLE 12       GLOBAL PHARMACOGENOMICS MARKET SHARE FOR POLYMERASE CHAIN REACTION, BY REGION, 2017 – 2029 ($ MILLION)       

TABLE 13       GLOBAL PHARMACOGENOMICS MARKET SHARE FOR GEL ELECTROPHORESIS, BY REGION, 2017 – 2029 ($ MILLION)          

TABLE 14       GLOBAL PHARMACOGENOMICS MARKET SHARE FOR MASS SPECTROMETRY, BY REGION, 2017 – 2029 ($ MILLION)          

TABLE 15       GLOBAL PHARMACOGENOMICS MARKET SHARE FOR MICROARRAY, BY REGION, 2017 – 2029 ($ MILLION)   

TABLE 16       GLOBAL PHARMACOGENOMICS MARKET SHARE FOR HYBRIDIZATION, BY REGION, 2017 – 2029 ($ MILLION)   

TABLE 17       GLOBAL PHARMACOGENOMICS MARKET SHARE FOR OTHERS, BY REGION, 2017 – 2029 ($ MILLION)    

TABLE 18       PREVALENCE OF HIV-AIDS ACROSS WHO REGIONS IN 2O2O

TABLE 19       GLOBAL PHARMACOGENOMICS MARKET SHARE, BY APPLICATION, 2017—2029 ($MILLION)    

TABLE 20       GLOBAL PHARMACOGENOMICS MARKET SHARE FOR CARDIOVASCULAR DISEASE, BY REGION, 2017 – 2029 ($ MILLION)    

TABLE 21       GLOBAL PHARMACOGENOMICS MARKET SHARE FOR INFECTIOUS DISEASES, BY REGION, 2017 – 2029 ($ MILLION)          

TABLE 22       GLOBAL PHARMACOGENOMICS MARKET SHARE FOR ONCOLOGY, BY REGION, 2017 – 2029 ($ MILLION) 

TABLE 23       GLOBAL PHARMACOGENOMICS MARKET SHARE FOR NEUROLOGICAL DISEASES, BY REGION, 2017 – 2029 ($ MILLION)          

TABLE 24       GLOBAL PHARMACOGENOMICS MARKET SHARE FOR PSYCHIATRY, BY REGION, 2017 – 2029 ($ MILLION)   

TABLE 25       GLOBAL PHARMACOGENOMICS MARKET SHARE FOR PAIN MANAGEMENT AND TRAUMA, BY REGION, 2017 – 2029 ($ MILLION)          

TABLE 26       GLOBAL PHARMACOGENOMICS MARKET SHARE FOR OTHERS, BY REGION, 2017 – 2029 ($ MILLION)    

TABLE 27       GLOBAL PHARMACOGENOMICS MARKET SHARE, BY END USERS, 2017—2029 ($MILLION)    

TABLE 28       GLOBAL PHARMACOGENOMICS MARKET SHARE FOR BIO-PHARMACEUTICAL COMPANIES, BY REGION, 2017 – 2029 ($ MILLION)    

TABLE 29       GLOBAL PHARMACOGENOMICS MARKET SHARE FOR RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2017 – 2029 ($ MILLION)     

TABLE 30       GLOBAL PHARMACOGENOMICS MARKET SHARE FOR CONTRACT RESEARCH ORGANIZATION AND MOLECULAR DIAGNOSTICS LABS, BY REGION, 2017 – 2029 ($ MILLION)           

TABLE 31       GLOBAL PHARMACOGENOMICS MARKET SHARE FOR OTHERS, BY REGION, 2017 – 2029 ($ MILLION)    

TABLE 32       GLOBAL PHARMACOGENOMICS MARKET SHARE VALUE, BY REGION, 2017—2029 ($MILLION)    

TABLE 33       AMERICAS PHARMACOGENOMICS MARKET SHARE VALUE, BY REGION, 2017—2029 ($MILLION)    

TABLE 34       AMERICAS PHARMACOGENOMICS MARKET SHARE VALUE, BY PRODUCTS AND SERVICES, 2017—2029 ($MILLION)         

TABLE 35       AMERICAS PHARMACOGENOMICS MARKET SHARE VALUE, BY TECHNOLOGY, 2017—2029 ($MILLION)    

TABLE 36       AMERICAS PHARMACOGENOMICS MARKET SHARE VALUE, BY APPLICATION, 2017—2029 ($MILLION)    

TABLE 37       AMERICAS PHARMACOGENOMICS MARKET SHARE VALUE, BY END USERS, 2017—2029 ($MILLION)     

TABLE 38       NORTH AMERICA PHARMACOGENOMICS MARKET SHARE VALUE, BY COUNTRY, 2017—2029 ($MILLION)    

TABLE 39       NORTH AMERICA PHARMACOGENOMICS MARKET SHARE VALUE, BY PRODUCTS AND SERVICES, 2017—2029 ($MILLION)            

TABLE 40       NORTH AMERICA PHARMACOGENOMICS MARKET SHARE VALUE, BY TECHNOLOGY, 2017—2029 ($MILLION)    

TABLE 41       NORTH AMERICA PHARMACOGENOMICS MARKET SHARE VALUE, BY APPLICATION, 2017—2029 ($MILLION)    

TABLE 42       NORTH AMERICA PHARMACOGENOMICS MARKET SHARE VALUE, BY END USERS, 2017—2029 ($MILLION)    

TABLE 43       THE U.S. PHARMACOGENOMICS MARKET SHARE VALUE, BY PRODUCTS AND SERVICES, 2017—2029 ($MILLION)         

TABLE 44       THE U.S. PHARMACOGENOMICS MARKET SHARE VALUE, BY TECHNOLOGY, 2017—2029 ($MILLION)     

TABLE 45       THE U.S. PHARMACOGENOMICS MARKET SHARE VALUE, BY APPLICATION, 2017—2029 ($MILLION)     

TABLE 46       THE U.S. PHARMACOGENOMICS MARKET SHARE VALUE, BY END USERS, 2017—2029 ($MILLION)     

TABLE 47       CANADA PHARMACOGENOMICS MARKET SHARE VALUE, BY PRODUCTS AND SERVICES, 2017—2029 ($MILLION)         

TABLE 48       CANADA PHARMACOGENOMICS MARKET SHARE VALUE, BY TECHNOLOGY, 2017—2029 ($MILLION)     

TABLE 49       CANADA PHARMACOGENOMICS MARKET SHARE VALUE, BY APPLICATION, 2017—2029 ($MILLION)     

TABLE 50       CANADA PHARMACOGENOMICS MARKET SHARE VALUE, BY END USERS, 2017—2029 ($MILLION)     

TABLE 51       SOUTH AMERICA PHARMACOGENOMICS MARKET SHARE VALUE, BY PRODUCTS AND SERVICES, 2017—2029 ($MILLION)            

TABLE 52       SOUTH AMERICA PHARMACOGENOMICS MARKET SHARE VALUE, BY TECHNOLOGY, 2017—2029 ($MILLION)    

TABLE 53       SOUTH AMERICA PHARMACOGENOMICS MARKET SHARE VALUE, BY APPLICATION, 2017—2029 ($MILLION)    

TABLE 54       SOUTH AMERICA PHARMACOGENOMICS MARKET SHARE VALUE, BY END USERS, 2017—2029 ($MILLION)    

TABLE 55       EUROPE PHARMACOGENOMICS MARKET SHARE VALUE, BY COUNTRY, 2017 – 2029 ($MILLION)    

TABLE 56       EUROPE PHARMACOGENOMICS MARKET SHARE VALUE, BY PRODUCTS AND SERVICES, 2017—2029 ($MILLION)         

TABLE 57       EUROPE PHARMACOGENOMICS MARKET SHARE VALUE, BY TECHNOLOGY, 2017—2029 ($MILLION)     

TABLE 58       EUROPE PHARMACOGENOMICS MARKET SHARE VALUE, BY APPLICATION, 2017—2029 ($MILLION)     

TABLE 59       EUROPE PHARMACOGENOMICS MARKET SHARE VALUE, BY END USERS, 2017—2029 ($MILLION)     

TABLE 60       U.K. PHARMACOGENOMICS MARKET SHARE VALUE, BY PRODUCTS AND SERVICES, 2017—2029 ($MILLION)    

TABLE 61       U.K. PHARMACOGENOMICS MARKET SHARE VALUE, BY TECHNOLOGY, 2017—2029 ($MILLION)    

TABLE 62       U.K. PHARMACOGENOMICS MARKET SHARE VALUE, BY APPLICATION, 2017—2029 ($MILLION)    

TABLE 63       U.K. PHARMACOGENOMICS MARKET SHARE VALUE, BY END USERS, 2017—2029 ($MILLION)    

TABLE 64       GERMANY PHARMACOGENOMICS MARKET SHARE VALUE, BY PRODUCTS AND SERVICES, 2017—2029 ($MILLION)         

TABLE 65       GERMANY PHARMACOGENOMICS MARKET SHARE VALUE, BY TECHNOLOGY, 2017—2029 ($MILLION)    

TABLE 66       GERMANY PHARMACOGENOMICS MARKET SHARE VALUE, BY APPLICATION, 2017—2029 ($MILLION)     

TABLE 67       GERMANY PHARMACOGENOMICS MARKET SHARE VALUE, BY END USERS, 2017—2029 ($MILLION)     

TABLE 68       FRANCE PHARMACOGENOMICS MARKET SHARE VALUE, BY PRODUCTS AND SERVICES, 2017—2029 ($MILLION)         

TABLE 69       FRANCE PHARMACOGENOMICS MARKET SHARE VALUE, BY TECHNOLOGY, 2017—2029 ($MILLION)     

TABLE 70       FRANCE PHARMACOGENOMICS MARKET SHARE VALUE, BY APPLICATION, 2017—2029 ($MILLION)     

TABLE 71       FRANCE PHARMACOGENOMICS MARKET SHARE VALUE, BY END USERS, 2017—2029 ($MILLION)     

TABLE 72       SPAIN PHARMACOGENOMICS MARKET SHARE VALUE, BY PRODUCTS AND SERVICES, 2017—2029 ($MILLION)         

TABLE 73       SPAIN PHARMACOGENOMICS MARKET SHARE VALUE, BY TECHNOLOGY, 2017—2029 ($MILLION)     

TABLE 74       SPAIN PHARMACOGENOMICS MARKET SHARE VALUE, BY APPLICATION, 2017—2029 ($MILLION)     

TABLE 75       SPAIN PHARMACOGENOMICS MARKET SHARE VALUE, BY END USERS, 2017—2029 ($MILLION)    

TABLE 76       ITALY PHARMACOGENOMICS MARKET SHARE VALUE, BY PRODUCTS AND SERVICES, 2017—2029 ($MILLION)    

TABLE 77       ITALY PHARMACOGENOMICS MARKET SHARE VALUE, BY TECHNOLOGY, 2017—2029 ($MILLION)     

TABLE 78       ITALY PHARMACOGENOMICS MARKET SHARE VALUE, BY APPLICATION, 2017—2029 ($MILLION)     

TABLE 79       ITALY PHARMACOGENOMICS MARKET SHARE VALUE, BY END USERS, 2017—2029 ($MILLION)    

TABLE 80       ROE PHARMACOGENOMICS MARKET SHARE VALUE, BY PRODUCTS AND SERVICES, 2017—2029 ($MILLION)    

TABLE 81       ROE PHARMACOGENOMICS MARKET SHARE VALUE, BY TECHNOLOGY, 2017—2029 ($MILLION)    

TABLE 82       ROE PHARMACOGENOMICS MARKET SHARE VALUE, BY APPLICATION, 2017—2029 ($MILLION)    

TABLE 83       ROE PHARMACOGENOMICS MARKET SHARE VALUE, BY END USERS, 2017—2029 ($MILLION)    

TABLE 84       PREVALENCE OF CANCER BY TYPE IN APAC, 2020      

TABLE 85       ASIA PACIFIC PHARMACOGENOMICS MARKET SHARE VALUE, BY COUNTRY, 2017—2029 ($MILLION)     

TABLE 86       ASIA PACIFIC PHARMACOGENOMICS MARKET SHARE VALUE, BY PRODUCTS AND SERVICES, 2017—2029 ($MILLION)         

TABLE 87       ASIA PACIFIC PHARMACOGENOMICS MARKET SHARE VALUE, BY TECHNOLOGY, 2017—2029 ($MILLION)    

TABLE 88       ASIA PACIFIC PHARMACOGENOMICS MARKET SHARE VALUE, BY APPLICATION, 2017—2029 ($MILLION)    

TABLE 89       ASIA PACIFIC PHARMACOGENOMICS MARKET SHARE VALUE, BY END USERS, 2017—2029 ($MILLION)    

TABLE 90       CHINA PHARMACOGENOMICS MARKET SHARE VALUE, BY PRODUCTS AND SERVICES, 2017—2029 ($MILLION)         

TABLE 91       CHINA PHARMACOGENOMICS MARKET SHARE VALUE, BY TECHNOLOGY, 2017—2029 ($MILLION)     

TABLE 92       CHINA PHARMACOGENOMICS MARKET SHARE VALUE, BY APPLICATION, 2017—2029 ($MILLION)     

TABLE 93       CHINA PHARMACOGENOMICS MARKET SHARE VALUE, BY END USERS, 2017—2029 ($MILLION)    

TABLE 94       JAPAN PHARMACOGENOMICS MARKET SHARE VALUE, BY PRODUCTS AND SERVICES, 2017—2029 ($MILLION)         

TABLE 95       JAPAN PHARMACOGENOMICS MARKET SHARE VALUE, BY TECHNOLOGY, 2017—2029 ($MILLION)     

TABLE 96       JAPAN PHARMACOGENOMICS MARKET SHARE VALUE, BY APPLICATION, 2017—2029 ($MILLION)     

TABLE 97       JAPAN PHARMACOGENOMICS MARKET SHARE VALUE, BY END USERS, 2017—2029 ($MILLION)    

TABLE 98       INDIA PHARMACOGENOMICS MARKET SHARE VALUE, BY PRODUCTS AND SERVICES, 2017—2029 ($MILLION)         

TABLE 99       INDIA PHARMACOGENOMICS MARKET SHARE VALUE, BY TECHNOLOGY, 2017—2029 ($MILLION)     

TABLE 100     INDIA PHARMACOGENOMICS MARKET SHARE VALUE, BY APPLICATION, 2017—2029 ($MILLION)     

TABLE 101     INDIA PHARMACOGENOMICS MARKET SHARE VALUE, BY END USERS, 2017—2029 ($MILLION)    

TABLE 102     AUSTRALIA PHARMACOGENOMICS MARKET SHARE VALUE, BY PRODUCTS AND SERVICES, 2017—2029 ($MILLION)         

TABLE 103     AUSTRALIA PHARMACOGENOMICS MARKET SHARE VALUE, BY TECHNOLOGY, 2017—2029 ($MILLION)    

TABLE 104     AUSTRALIA PHARMACOGENOMICS MARKET SHARE VALUE, BY APPLICATION, 2017—2029 ($MILLION)    

TABLE 105     AUSTRALIA PHARMACOGENOMICS MARKET SHARE VALUE, BY END USERS, 2017—2029 ($MILLION)     

TABLE 106     SOUTH KOREA PHARMACOGENOMICS MARKET SHARE VALUE, BY PRODUCTS AND SERVICES, 2017—2029 ($MILLION)         

TABLE 107     SOUTH KOREA PHARMACOGENOMICS MARKET SHARE VALUE, BY TECHNOLOGY, 2017—2029 ($MILLION)    

TABLE 108     SOUTH KOREA PHARMACOGENOMICS MARKET SHARE VALUE, BY APPLICATION, 2017—2029 ($MILLION)    

TABLE 109     SOUTH KOREA PHARMACOGENOMICS MARKET SHARE VALUE, BY END USERS, 2017—2029 ($MILLION)    

TABLE 110     ROA PHARMACOGENOMICS MARKET SHARE VALUE, BY PRODUCTS AND SERVICES, 2017—2029 ($MILLION)    

TABLE 111     ROA PHARMACOGENOMICS MARKET SHARE VALUE, BY TECHNOLOGY, 2017—2029 ($MILLION)    

TABLE 112     ROA PHARMACOGENOMICS MARKET SHARE VALUE, BY APPLICATION, 2017—2029 ($MILLION)    

TABLE 113     ROA PHARMACOGENOMICS MARKET SHARE VALUE, BY END USERS, 2017—2029 ($MILLION)    

TABLE 114     MEA PHARMACOGENOMICS MARKET SHARE VALUE, BY COUNTRY, 2017—2029 ($MILLION)    

TABLE 115     MEA PHARMACOGENOMICS MARKET SHARE VALUE, BY PRODUCTS AND SERVICES, 2017—2029 ($MILLION)    

TABLE 116     MEA PHARMACOGENOMICS MARKET SHARE VALUE, BY TECHNOLOGY, 2017—2029 ($MILLION)    

TABLE 117     MEA PHARMACOGENOMICS MARKET SHARE VALUE, BY APPLICATION, 2017—2029 ($MILLION)    

TABLE 118     MEA PHARMACOGENOMICS MARKET SHARE VALUE, BY END USERS, 2017—2029 ($MILLION)    

TABLE 119     MIDDLE EAST PHARMACOGENOMICS MARKET SHARE VALUE, BY PRODUCTS AND SERVICES, 2017—2029 ($MILLION)         

TABLE 120     MIDDLE EAST PHARMACOGENOMICS MARKET SHARE VALUE, BY TECHNOLOGY, 2017—2029 ($MILLION)    

TABLE 121     MIDDLE EAST PHARMACOGENOMICS MARKET SHARE VALUE, BY APPLICATION, 2017—2029 ($MILLION)    

TABLE 122     MIDDLE EAST PHARMACOGENOMICS MARKET SHARE VALUE, BY END USERS, 2017—2029 ($MILLION)    

TABLE 123     AFRICA PHARMACOGENOMICS MARKET SHARE VALUE, BY PRODUCTS AND SERVICES, 2017—2029 ($MILLION)         

TABLE 124     AFRICA PHARMACOGENOMICS MARKET SHARE VALUE, BY TECHNOLOGY, 2017—2029 ($MILLION)     

TABLE 125     AFRICA PHARMACOGENOMICS MARKET SHARE VALUE, BY APPLICATION, 2017—2029 ($MILLION)     

TABLE 126     AFRICA PHARMACOGENOMICS MARKET SHARE VALUE, BY END USERS, 2017—2029 ($MILLION)    

TABLE 127     LIST OF FEW DIAGNOSTIC LABS AND PROVIDERS OF PHARMACOGENOMICS SERVICES       

TABLE 128     Company 1: FINANCIAL OVERVIEW (USD MILLION)    

TABLE 129     Company 1: KEY PRODUCT PORTFOLIO  

List of Figures

FIGURE 1       MARKET SNAPSHOT            

FIGURE 2       SEGMENT OVERVIEW: SNAPSHOT           

FIGURE 3       REGIONAL MARKET CAGR 2020 (%): SNAPSHOT          

FIGURE 4       MARKET SEGMENTATION  

FIGURE 5       PORTERS OVERVIEW           

FIGURE 6       BARGAINING POWER OF SUPPLIERS       

FIGURE 7       BARGAINING POWER OF BUYERS            

FIGURE 8       THREAT OF SUBSTITUTE PRODUCTS       

FIGURE 9       THREAT OF NEW ENTRANTS         

FIGURE 10     COMPETITIVE RIVALRY       

FIGURE 11     SWOT ANALYSIS OF GLOBAL PHARMACOGENOMICS MARKET         

FIGURE 12     MARKET DYNAMICS: SNAPSHOT 

FIGURE 13     CANCER STATISTICS, 2020

FIGURE 14     MAJOR GENOMICS & PHARMCOGENOMIC PROJECTS ACROSS THE GLOBE          

FIGURE 15     ADVERSE DRUG REACTION STATISTICS TO SOME COMMONLY USED PRESCRIPTION DRUGS/THERAPY     

FIGURE 16     PRECISION MEDICINE MARKET VALUE AND FORCAST (PARENT MARKET) 

FIGURE 17     GENOMICS MARKET VALUE AND FORECAST (PARENT MARKET)      

FIGURE 18     PHARMACOGENETICS OF COVID-19 TREATMENT        

FIGURE 19     GLOBAL PHARMACOGENOMICS MARKET SHARE, BY PRODUCTS AND SERVICES, 2020 & 2029 ($MILLION)   

FIGURE 20     GLOBAL PHARMACOGENOMICS MARKET SHARE, BY TECHNOLOGY, 2020 & 2029 ($MILLION)    

FIGURE 21     GLOBAL PHARMACOGENOMICS MARKET SHARE, BY APPLICATION, 2020 & 2029 ($MILLION)    

FIGURE 22     GLOBAL PHARMACOGENOMICS MARKET SHARE, BY END USERS, 2020 & 2029 ($MILLION)    

FIGURE 23     CLUSTER ANALYSIS: MARKET OPPORTUNITIES AND TRENDS ANALYSIS BY REGION           

FIGURE 24     GLOBAL PHARMACOGENOMICS MARKET SHARE, BY REGION, 2020 (%)   

FIGURE 25     AMERICAS PHARMACOGENOMICS MARKET SHARE, BY CONTINENT, 2020 (%)   

FIGURE 26     NORTH AMERICA PHARMACOGENOMICS MARKET SHARE, BY COUNTRY, 2020 (%)           

FIGURE 27     DEMOGRAPHIC TRENDS (GERIATRIC POPULATION AS % OF TOTAL)           

FIGURE 28     EUROPE PHARMACOGENOMICS MARKET SHARE, BY COUNTRY, 2020 (%)           

FIGURE 29     ASIA PACIFIC PHARMACOGENOMICS MARKET SHARE, BY COUNTRY, 2020 (%)   

FIGURE 30     MEA PHARMACOGENOMICS MARKET SHARE, BY COUNTRY, 2020 (%)      

FIGURE 31     COMPETITIVE LANDSCAPE SNAPSHOT   

FIGURE 32     COMPETITIVE ANALYSIS OF KEY MARKET OPERANTS 

FIGURE 33     FINANCIAL COMPARISON SNAPSHOT: KEY PLAYERS OF THE MARKET

Report Description Download Sample

Copyright . All rights Reserved By Straits Research